Hls Therapeutics Stock Volatility

HLTRF Stock  USD 2.82  0.11  3.75%   
HLS Therapeutics appears to be very risky, given 3 months investment horizon. HLS Therapeutics holds Efficiency (Sharpe) Ratio of 0.0699, which attests that the entity had a 0.0699 % return per unit of volatility over the last 3 months. We have found twenty-seven technical indicators for HLS Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize HLS Therapeutics' market risk adjusted performance of 0.3592, and Risk Adjusted Performance of 0.0647 to validate if our risk estimates are consistent with your expectations. Key indicators related to HLS Therapeutics' volatility include:
720 Days Market Risk
Chance Of Distress
720 Days Economic Sensitivity
HLS Therapeutics Pink Sheet volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of HLS daily returns, and it is calculated using variance and standard deviation. We also use HLS's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of HLS Therapeutics volatility.
  
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as HLS Therapeutics can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of HLS Therapeutics at lower prices to lower their average cost per share. Similarly, when the prices of HLS Therapeutics' stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.

Moving against HLS Pink Sheet

  0.55HPQ HP IncPairCorr
  0.55DD Dupont De Nemours Earnings Call This WeekPairCorr
  0.49AA Alcoa CorpPairCorr
  0.48MCD McDonalds Earnings Call This WeekPairCorr
  0.47XOM Exxon Mobil Corp Earnings Call TodayPairCorr
  0.45TAK Takeda PharmaceuticalPairCorr
  0.4ZTLLF ZonetailPairCorr
  0.39VZ Verizon CommunicationsPairCorr
  0.37INTC IntelPairCorr

HLS Therapeutics Market Sensitivity And Downside Risk

HLS Therapeutics' beta coefficient measures the volatility of HLS pink sheet compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents HLS pink sheet's returns against your selected market. In other words, HLS Therapeutics's beta of 0.68 provides an investor with an approximation of how much risk HLS Therapeutics pink sheet can potentially add to one of your existing portfolios. HLS Therapeutics shows above-average downside volatility for the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure HLS Therapeutics' pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact HLS Therapeutics' pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze HLS Therapeutics Demand Trend
Check current 90 days HLS Therapeutics correlation with market (Dow Jones Industrial)

HLS Beta

    
  0.68  
HLS standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

Standard Deviation

    
  3.73  
It is essential to understand the difference between upside risk (as represented by HLS Therapeutics's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of HLS Therapeutics' daily returns or price. Since the actual investment returns on holding a position in hls pink sheet tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in HLS Therapeutics.

HLS Therapeutics Pink Sheet Volatility Analysis

Volatility refers to the frequency at which HLS Therapeutics pink sheet price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with HLS Therapeutics' price changes. Investors will then calculate the volatility of HLS Therapeutics' pink sheet to predict their future moves. A pink sheet that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A pink sheet with relatively stable price changes has low volatility. A highly volatile pink sheet is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of HLS Therapeutics' volatility:

Historical Volatility

This type of pink sheet volatility measures HLS Therapeutics' fluctuations based on previous trends. It's commonly used to predict HLS Therapeutics' future behavior based on its past. However, it cannot conclusively determine the future direction of the pink sheet.

Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for HLS Therapeutics' current market price. This means that the pink sheet will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on HLS Therapeutics' to be redeemed at a future date.
Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. HLS Therapeutics Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.

HLS Therapeutics Projected Return Density Against Market

Assuming the 90 days horizon HLS Therapeutics has a beta of 0.6833 . This usually indicates as returns on the market go up, HLS Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding HLS Therapeutics will be expected to be much smaller as well.
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to HLS Therapeutics or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that HLS Therapeutics' price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a HLS pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
HLS Therapeutics has an alpha of 0.1772, implying that it can generate a 0.18 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Predicted Return Density   
       Returns  
HLS Therapeutics' volatility is measured either by using standard deviation or beta. Standard deviation will reflect the average amount of how hls pink sheet's price will differ from the mean after some time.To get its calculation, you should first determine the mean price during the specified period then subtract that from each price point.

What Drives a HLS Therapeutics Price Volatility?

Several factors can influence a pink sheet's market volatility:

Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.

Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.

The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.

HLS Therapeutics Pink Sheet Risk Measures

Assuming the 90 days horizon the coefficient of variation of HLS Therapeutics is 1430.99. The daily returns are distributed with a variance of 13.89 and standard deviation of 3.73. The mean deviation of HLS Therapeutics is currently at 1.93. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.84
α
Alpha over Dow Jones
0.18
β
Beta against Dow Jones0.68
σ
Overall volatility
3.73
Ir
Information ratio 0.04

HLS Therapeutics Pink Sheet Return Volatility

HLS Therapeutics historical daily return volatility represents how much of HLS Therapeutics pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company shows 3.7269% volatility of returns over 90 . By contrast, Dow Jones Industrial accepts 0.8451% volatility on return distribution over the 90 days horizon.
 Performance 
       Timeline  

About HLS Therapeutics Volatility

Volatility is a rate at which the price of HLS Therapeutics or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of HLS Therapeutics may increase or decrease. In other words, similar to HLS's beta indicator, it measures the risk of HLS Therapeutics and helps estimate the fluctuations that may happen in a short period of time. So if prices of HLS Therapeutics fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. HLS Therapeutics Inc. was founded in 2018 and is headquartered in Etobicoke, Canada. Hls Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 92 people.
HLS Therapeutics' stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on HLS Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much HLS Therapeutics' price varies over time.

3 ways to utilize HLS Therapeutics' volatility to invest better

Higher HLS Therapeutics' stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of HLS Therapeutics stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. HLS Therapeutics stock volatility can provide helpful information for making investment decisions in the following ways:
  • Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of HLS Therapeutics investment. A higher volatility means higher risk and potentially larger changes in value.
  • Identifying Opportunities: High volatility in HLS Therapeutics' stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
  • Diversification: Understanding how the volatility of HLS Therapeutics' stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Remember it's essential to remember that stock volatility is just one of many factors to consider when making investment decisions, and it should be used in conjunction with other fundamental and technical analysis tools.

HLS Therapeutics Investment Opportunity

HLS Therapeutics has a volatility of 3.73 and is 4.39 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of HLS Therapeutics is lower than 33 percent of all global equities and portfolios over the last 90 days. You can use HLS Therapeutics to protect your portfolios against small market fluctuations. The pink sheet experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of HLS Therapeutics to be traded at $2.71 in 90 days.

Average diversification

The correlation between HLS Therapeutics and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding HLS Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

HLS Therapeutics Additional Risk Indicators

The analysis of HLS Therapeutics' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in HLS Therapeutics' investment and either accepting that risk or mitigating it. Along with some common measures of HLS Therapeutics pink sheet's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential pink sheets, we recommend comparing similar pink sheets with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

HLS Therapeutics Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against HLS Therapeutics as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. HLS Therapeutics' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, HLS Therapeutics' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to HLS Therapeutics.

Complementary Tools for HLS Pink Sheet analysis

When running HLS Therapeutics' price analysis, check to measure HLS Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HLS Therapeutics is operating at the current time. Most of HLS Therapeutics' value examination focuses on studying past and present price action to predict the probability of HLS Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HLS Therapeutics' price. Additionally, you may evaluate how the addition of HLS Therapeutics to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals